טוען...
The Emerging Science of Precision Medicine and Pharmacogenomics for Parkinson’s Disease
Current therapies for Parkinson’s disease are problematic because they are symptomatic and have adverse effects. New drugs have failed in clinical trials due to inadequate efficacy. At the core of the problem is trying to make one drug work for all Parkinson’s disease patients, when we know this pre...
שמור ב:
| הוצא לאור ב: | Mov Disord |
|---|---|
| מחבר ראשי: | |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570630/ https://ncbi.nlm.nih.gov/pubmed/28686320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.27099 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|